These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 15503324)
21. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts. Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441 [TBL] [Abstract][Full Text] [Related]
22. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab. Hsu YH; Ferl GZ; Ng CM Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680 [TBL] [Abstract][Full Text] [Related]
23. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography. de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911 [TBL] [Abstract][Full Text] [Related]
24. Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma. Boschi F; Marzola P; Sandri M; Nicolato E; Galiè M; Fiorini S; Merigo F; Lorusso V; Chaabane L; Sbarbati A MAGMA; 2008 May; 21(3):169-76. PubMed ID: 18317830 [TBL] [Abstract][Full Text] [Related]
25. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369 [TBL] [Abstract][Full Text] [Related]
26. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973 [TBL] [Abstract][Full Text] [Related]
27. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results. Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086 [TBL] [Abstract][Full Text] [Related]
28. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293 [TBL] [Abstract][Full Text] [Related]
29. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC Pediatr Radiol; 1998 Feb; 28(2):67-78. PubMed ID: 9472047 [TBL] [Abstract][Full Text] [Related]
30. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model. Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948 [TBL] [Abstract][Full Text] [Related]
31. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA. Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439 [TBL] [Abstract][Full Text] [Related]
32. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model. Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145 [TBL] [Abstract][Full Text] [Related]
33. Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis. Haney CR; Fan X; Markiewicz E; Mustafi D; Karczmar GS; Stadler WM Technol Cancer Res Treat; 2013 Feb; 12(1):71-8. PubMed ID: 22905809 [TBL] [Abstract][Full Text] [Related]
34. Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers. Wu X; Jeong EK; Emerson L; Hoffman J; Parker DL; Lu ZR Mol Pharm; 2010 Feb; 7(1):41-8. PubMed ID: 19958031 [TBL] [Abstract][Full Text] [Related]
35. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model. Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584 [TBL] [Abstract][Full Text] [Related]
36. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033 [TBL] [Abstract][Full Text] [Related]
37. Dynamic contrast-enhanced magnetic resonance imaging at 1.5 Tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice. de Lussanet QG; Beets-Tan RG; Backes WH; van der Schaft DW; van Engelshoven JM; Mayo KH; Griffioen AW Eur J Cancer; 2004 May; 40(8):1262-8. PubMed ID: 15110892 [TBL] [Abstract][Full Text] [Related]
38. An MRA study of vascular stenosis in a pig model using CH3-DTPA-Gd (NMS60) and Gd-DTPA. D'Arceuil HE; de Crespigny AJ; Pelc L; Howard D; Alley M; Seri S; Hashiguchi Y; Nakatani A; Moseley ME Magn Reson Imaging; 2004 Nov; 22(9):1243-8. PubMed ID: 15607095 [TBL] [Abstract][Full Text] [Related]
39. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
40. In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. Huuse EM; Moestue SA; Lindholm EM; Bathen TF; Nalwoga H; Krüger K; Bofin A; Maelandsmo GM; Akslen LA; Engebraaten O; Gribbestad IS J Magn Reson Imaging; 2012 May; 35(5):1098-107. PubMed ID: 22170753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]